|
FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11363096
|
Savarino V et al. |
Helicobacter pylori eradication and reinfection. |
1995 |
Lancet |
pmid:7783564
|
Odenholt-Tornqvist I et al. |
Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695310
|
Ives DV et al. |
Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. |
1995 |
AIDS |
pmid:7755914
|
Weits J and Sprenger HG |
[Surgical treatment of lymphadenitis caused by non-tuberculous mycobacteria in children]. |
1995 |
Ned Tijdschr Geneeskd |
pmid:8524431
|
Adamek RJ et al. |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection]. |
1995 |
Dtsch. Med. Wochenschr. |
pmid:7889816
|
Xu G et al. |
[Effect of clarithromycin on macrophage functions]. |
1995 |
Kansenshogaku Zasshi |
pmid:7594777
|
Gelber RH et al. |
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice. |
1995 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:7602221
|
Milde P et al. |
Cutaneous bacillary angiomatosis in a patient with chronic lymphocytic leukemia. |
1995 |
Arch Dermatol |
pmid:7543264
|
Nightingale SD et al. |
Clarithromycin-induced mania in two patients with AIDS. |
1995 |
Clin. Infect. Dis. |
pmid:7548513
|
Matsiota-Bernard P et al. |
Mycobacterium genavense infection in a patient with AIDS who was successfully treated with clarithromycin. |
1995 |
Clin. Infect. Dis. |
pmid:7548515
|
Citron DM et al. |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children. |
1995 |
Clin. Infect. Dis. |
pmid:7548597
|
Ishii K et al. |
A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters. |
1995 |
Biol. Pharm. Bull. |
pmid:7550125
|
Harris AW et al. |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605863
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Yousfi MM et al. |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605865
|
Chevalley GF et al. |
[Uveitis associated with rifabutin treatment. Apropos of 3 patients]. |
1995 |
Klin Monbl Augenheilkd |
pmid:7609395
|
Blum AL et al. |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy]. |
1995 |
Leber Magen Darm |
pmid:7609589
|
Tamaoki J et al. |
Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. |
1995 |
J. Allergy Clin. Immunol. |
pmid:7722166
|
Conte JE et al. |
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7726492
|
Lacassin F et al. |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695324
|
Labenz J and Börsch G |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7733070
|
Schütze K and Hentschel E |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin. |
1995 |
Z Gastroenterol |
pmid:8600661
|
Tseng AL and Walmsley SL |
Rifabutin-associated uveitis. |
1995 |
Ann Pharmacother |
pmid:8573961
|
Moayyedi P et al. |
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574714
|
Fujioka T et al. |
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574733
|
Deltenre M et al. |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574734
|
Fukuda Y et al. |
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574735
|
Rizzato G et al. |
Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. |
1995 |
Eur. Respir. J. |
pmid:7789484
|
Graham DY |
Clarithromycin for treatment of Helicobacter pylori infections. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574737
|
Takimoto T et al. |
Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574739
|
Pavlopoulou J et al. |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children. |
1995 |
J Chemother |
pmid:8904139
|
Stafstrom CE et al. |
Erythromycin-induced carbamazepine toxicity: a continuing problem. |
1995 |
Arch Pediatr Adolesc Med |
pmid:7827672
|
Kadayifçi A et al. |
Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. |
1995 |
Am. J. Gastroenterol. |
pmid:7872307
|
Wallace RJ et al. |
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. |
1995 |
J. Infect. Dis. |
pmid:7876634
|
Moorthy RS and Rao NA |
Atypical mycobacterial wound infection after blepharoplasty. |
1995 |
Br J Ophthalmol |
pmid:7880802
|
Yoshizawa A et al. |
[Legionella pneumonia diagnosed by urinary antigen detection]. |
1995 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:7791279
|
Lounis N et al. |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793860
|
Fattorini L et al. |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793873
|
|
Abbott files SNDA for MAC prophylaxis. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11362606
|
Cohen Y et al. |
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793882
|
Pierce M |
Another perspective on MAC prophylaxis. Interview by Gordon Nary. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11362746
|
Furney SK et al. |
Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793895
|
Archange YR et al. |
Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11362747
|
|
Physician's aggressive preventive therapy differs. |
1995 |
AIDS Alert |
pmid:11362774
|
|
New drug applications sought. |
1995 |
AIDS Alert |
pmid:11362777
|
Smart T |
Cryptosporidiosis at ICAAC. |
1995 |
GMHC Treat Issues |
pmid:11362913
|
|
Researchers find new drugs to fight MAC. |
1995 |
AIDS Alert |
pmid:11362925
|
Claussen DW |
The most commonly prescribed medications in the United States: Part 3. |
1995 Jul-Aug |
Gastroenterol Nurs |
pmid:7654815
|
Hashisaki GT |
Update on macrolide antibiotics. |
1995 May-Jun |
Am J Otolaryngol |
pmid:7661309
|
Kees F et al. |
Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. |
1995 May-Jun |
Infection |
pmid:7499006
|
Sternon J et al. |
Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost of illness study. |
1995 Nov-Dec |
J. Int. Med. Res. |
pmid:8746608
|
Stein GE et al. |
A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. |
1995 Nov-Dec |
Pharmacotherapy |
pmid:8602379
|
Dalston MO et al. |
[Clarithromycin combined with pyrimethamine in cerebral toxoplasmosis--a report of 2 cases]. |
1995 Oct-Dec |
Rev. Soc. Bras. Med. Trop. |
pmid:8668843
|
Pinzani V et al. |
[Occurrence of anterior uveitis in a HIV patient treated with rifabutin, ethambutol, clarithromycin]. |
1995 Sep-Oct |
Therapie |
pmid:8571297
|
Morikawa K et al. |
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726002
|
Arain TM et al. |
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726034
|
Shafran SD et al. |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. |
1996 |
N. Engl. J. Med. |
pmid:8676931
|
Bowersox J |
CPCRA researchers present OI studies at Vancouver. |
1996 |
NIAID AIDS Agenda |
pmid:11363924
|
|
MAC management. |
1996 |
PI Perspect |
pmid:11363967
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Flurer CL |
Analysis of macrolide antibiotics by capillary electrophoresis. |
1996 |
Electrophoresis |
pmid:8900943
|
Segreti J et al. |
In vitro activity of macrolides against intracellular Legionella pneumophila. |
1996 |
Diagn. Microbiol. Infect. Dis. |
pmid:8902407
|
Pellegrin I et al. |
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages. |
1996 |
J. Antimicrob. Chemother. |
pmid:9182107
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Matsuoka N et al. |
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. |
1996 |
Clin. Exp. Immunol. |
pmid:9099936
|
Alarcón T et al. |
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9031877
|
Burucoa C et al. |
Western blot monitoring of disseminated Nocardia nova infection treated with clarithromycin, imipenem, and surgical drainage. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9031879
|
Ramirez Mayans JA et al. |
[Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin]. |
1996 |
Acta Gastroenterol. Latinoam. |
pmid:9363265
|
Thompson D and Oster G |
Use of terfenadine and contraindicated drugs. |
1996 |
JAMA |
pmid:8614120
|
Dammann HG |
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis. |
1996 |
Dig. Dis. Sci. |
pmid:8617126
|
Meyboom RH et al. |
[Possible potentiation of phenprocoumon by clarithromycin and roxithromycin]. |
1996 |
Ned Tijdschr Geneeskd |
pmid:8628425
|
Satoh K et al. |
Efficacy of clarithromycin in eradicating Helicobacter pylori. |
1996 |
J. Gastroenterol. |
pmid:8959520
|
Shimoyama T et al. |
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients. |
1996 |
J. Gastroenterol. |
pmid:8959522
|
Tonokatsu Y et al. |
Eradication of Helicobacter pylori followed by reinfection. |
1996 |
J. Gastroenterol. |
pmid:8959526
|
Murakami K et al. |
Atopic dermatitis successfully treated by eradication of Helicobacter pylori. |
1996 |
J. Gastroenterol. |
pmid:8959527
|
Diemer PR et al. |
[Rifabutin-induced hypopyon iritis in HIV infection]. |
1996 |
Klin Monbl Augenheilkd |
pmid:8965476
|
Labenz J |
[Current developments in Helicobacter pylori therapy]. |
1996 |
Leber Magen Darm |
pmid:8965606
|
Grau E et al. |
Interaction between clarithromycin and oral anticoagulants. |
1996 |
Ann Pharmacother |
pmid:8968465
|
Muñoz N et al. |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data. |
1996 |
IARC Sci. Publ. |
pmid:8923024
|
Dhaenens L et al. |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8877551
|
Chen S et al. |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592303
|
Liu W et al. |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592304
|
Xu G et al. |
[Effect of clarithromycin on cytocidal activity against Pseudomonas aeruginosa in mice peritoneal cavity]. |
1996 |
Kansenshogaku Zasshi |
pmid:8822058
|
Pijpers E et al. |
A clarithromycin-induced myasthenic syndrome. |
1996 |
Clin. Infect. Dis. |
pmid:8824993
|
Webb DD |
Practice guidelines for treatment of peptic ulcer disease. |
1996 |
JAMA |
pmid:8827959
|
Erah PO et al. |
Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832427
|
Vangala R and Cernek PK |
Hypersensitivity reaction to clarithromycin. |
1996 |
Ann Pharmacother |
pmid:8833572
|
Riff DS et al. |
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report. |
1996 |
Helicobacter |
pmid:9398874
|
Harford W et al. |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. |
1996 |
Helicobacter |
pmid:9398875
|
Schwartz H et al. |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. |
1996 |
Helicobacter |
pmid:9398876
|
Mehaffey PC et al. |
Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods. |
1996 |
J. Clin. Microbiol. |
pmid:8789046
|
Markham A and McTavish D |
Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders. |
1996 |
Drugs |
pmid:8741237
|
Unge P |
Review of Helicobacter pylori eradication regimens. |
1996 |
Scand. J. Gastroenterol. Suppl. |
pmid:8722388
|
Bazzoli F |
Italian omeprazole triple therapy--a 1-week regimen. |
1996 |
Scand. J. Gastroenterol. Suppl. |
pmid:8722395
|
Goddard AF and Logan RP |
Antimicrobial resistance and Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722530
|
Barry AL et al. |
Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722555
|
|
H. pylori treatment recognized by FDA. |
1996 |
Am J Health Syst Pharm |
pmid:8725200
|